TICKERNERD
Menu
CICIHealthcare · Healthcare Plans

CI Stock Forecast: The Cigna Group Price Predictions for 2026-2027

Last close, 18 Sept 2026
$275
−0.26% on the day

The 25 Wall Street analysts covering The Cigna Group hold a median 12-month price target of $340 — +23.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 69 of 100 as at 19 Sept 2026 — in the upper half.

Market cap
$72.7B
Ticker Nerd rank
69 / 100
Median analyst target
$340
Analysts covering
25
Revenue$71.4B+6.7% y/y
Operating income$2.4B
Net income$1.9B
Free cash flow−$718.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−2.0%
1M
−0.6%
YTD
+1.7%
1Y
−4.2%
From 52W high
−9.5%
From 52W low
+15.2%
$239
$304
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

CI stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores The Cigna Group on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 19 Sept 2026
69 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
97
Value
96
Growth
81
Issuance
71
Revisions
68
Quality
47
Momentum
45
Accruals
38
Size
4

Volatility (97): The share price has been relatively steady.

Accruals (38): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Size (4): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

CI stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on CI, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$250$300$350$400Oct 25Jan 26Apr 26Jul 26CIHigh $400Median $340Low $290

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says25 analysts
19 Buy6 Hold0 Sell
Low $290Median $340High $400

The green dot is the last close — the median target sits +23.5% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 4 moved their price target up and 2 moved it down.

DateFirmActionRatingTarget
4 Aug 2026JefferiesDowngradeHold$336 → $307
3 Aug 2026Raymond JamesDowngradeOutperform$350 → $320
31 July 2026BarclaysMaintainsEqual-Weight$304 → $310
31 July 2026GuggenheimMaintainsBuy$338 → $361
31 July 2026Wells FargoMaintainsEqual-Weight$305 → $307
9 July 2026BernsteinMaintainsOutperform—
9 July 2026BernsteinMaintainsOutperform$371 → $381
8 June 2026MizuhoMaintainsOutperform—
26 May 2026BarclaysDowngradeEqual-Weight—
22 May 2026UBSMaintainsBuy—
20 May 2026Deutsche BankDowngradeHold—
20 May 2026Morgan StanleyMaintainsOverweight—
5 May 2026BernsteinMaintainsOutperform—
4 May 2026GuggenheimMaintainsBuy—
1 May 2026BarclaysMaintainsOverweight—
1 May 2026Cantor FitzgeraldMaintainsOverweight—
1 May 2026RBC CapitalMaintainsOutperform—
1 May 2026Wells FargoMaintainsEqual-Weight—
20 Apr 2026JefferiesMaintainsBuy—
12 Mar 2026BernsteinUpgradeOutperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CI appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

CI vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 18 Sept 2026, The Cigna Group returned −4.2% against +16.3% for the S&P 500, dividends included.

CI vs S&P 500, last 12 monthsTotal return, rebased to 100
8090100110120Oct 25Jan 26Apr 26Jul 26CIS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

CI analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+0.4%
Analysts raising
19
Analysts cutting
2
Fundamentals

The Cigna Group (CI) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
11.4×

Cheaper than 55% of US stocks

Price / sales
0.3×

Cheaper than 90% of US stocks

Price / book
1.7×

Cheaper than 50% of US stocks

EV / EBITDA
7.7×

Cheaper than 46% of US stocks

Growth & margins
Revenue growth (YoY)
6.7%

Higher than 43% of US stocks

Earnings growth (YoY)
8.4%

Higher than 46% of US stocks

Gross margin
8.8%

Higher than 9% of US stocks

Operating margin
4.0%

Higher than 52% of US stocks

Net margin
2.3%

Higher than 53% of US stocks

Returns & dividend
Return on equity
16.8%

Higher than 77% of US stocks

Return on assets
4.5%

Higher than 73% of US stocks

Dividend yield
2.3%

Higher than 50% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

The Cigna Group (CI) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • The Cigna Group has a market value of $72.7B and an enterprise value of $97.7B.

  • Revenue in the twelve months to 30 June 2026: $281.3B. The latest quarter grew 6.7% year on year.

  • Net income over the same four quarters: $7.0B, a 2.5% net margin.

  • Diluted earnings per share, trailing twelve months: $24.17.

  • Free cash flow in the twelve months to 30 June 2026: $9.1B.

  • The Cigna Group spent $1.3B on share buybacks and $1.6B on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 263.6M.

  • Trailing P/E: 11.4×; forward P/E: 8.2× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 2.27%, paying out 25% of earnings.

  • The Cigna Group employs 65,669 people — $4.3M of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 19 Sept 2026

Data provided by Twelve Data

Peers

CI vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealthcare Plans
CompanyMarket capTKN rank
CIThe Cigna Group$72.7B
69
ELVElevance Health, Inc.$91.3B
68
CVSCVS Health Corp.$112.8B
88
HUMHumana, Inc.$46.5B
43
CNCCentene Corp.$32.0B
95
UNHUnitedHealth Group, Inc.$341.4B
77
MOHMolina Healthcare, Inc.$10.3B
35

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own The Cigna Group — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest CI news & analysis

Can Cigna's AI Push Help Rein In Rising Healthcare Costs?

Zacks Investment Research · 18 Sept 2026positive

Cigna (CI) is expanding its use of AI across care coordination and specialty pharmacy as part of efforts to manage elevated healthcare costs and improve access. The news highlights the company's ongoing push to apply artificial intelligence to health-plan operations.

Why it matters — A Cigna watcher would care because the company's deployment of AI in cost management and specialty pharmacy could be central to how it handles rising healthcare expenses and service delivery.

Is Volunteering Good for Your Health? New Research From The Cigna Group Finds a Strong Connection

PRNewsWire · 16 Sept 2026positive

The Cigna Group released new research from its Vitality in America report finding that volunteering is linked to better health, stronger community connection, and greater resilience. The report also connects employee volunteerism to higher job satisfaction, workplace pride, and engagement, and introduces a tool measuring the economic, health, and skills value generated through service.

Why it matters — The research highlights Cigna's focus on holistic health and well-being, positioning the company's data-driven insights on social connection and workplace wellness that could inform its products and brand.

Why Cigna (CI) is a Top Growth Stock for the Long-Term

Zacks Investment Research · 15 Sept 2026positive

Zacks Investment Research has highlighted Cigna (CI) as a top growth stock for long-term investors, recommending the use of its Zacks Style Scores to identify market-beating stocks.

Why it matters — This article suggests to CI watchers that the company is regarded by one research firm as having strong long-term growth potential relative to the broader market.

Cigna Group Executive Neville Everett Sells 617 Shares for $175,000

The Motley Fool · 9 Sept 2026neutral

Cigna Group executive Neville Everett sold 617 shares at $284.05 per share, totaling approximately $175,000, on September 3, 2026. The transaction represented 11% of the equity he held before the filing.

Why it matters — Insider share sales by a Cigna executive could be of interest to those tracking insider activity, though a relatively small disposition of holdings offers limited signal on company prospects.

The Cigna Group to Host Investor Day on September 30

PRNewsWire · 9 Sept 2026neutral

The Cigna Group announced that it will host its Investor Day on Wednesday, September 30, 2026. The announcement was made via press release from the company's Bloomfield, Connecticut headquarters.

Why it matters — The Investor Day will provide an opportunity for Cigna to present its strategy and updates directly to investors, making it a notable event for those following the company.

FAQ

Frequently asked questions about CI stock

What is the CI stock price forecast for 2026-2027?

The 25 Wall Street analysts covering The Cigna Group have a median 12-month price target of $340, with estimates ranging from $290 to $400. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is CI stock a buy right now?

Of the 25 analysts covering The Cigna Group, 19 rate it a Buy, 6 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks The Cigna Group 69 out of 100 across roughly 4,600 US stocks as at 19 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank CI?

As at 19 Sept 2026, The Cigna Group ranks 69 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (97 of 100).

Will CI stock go up?

No one can know that. What the data says: the median 12-month target from 25 analysts implies +23.5% from the last close, and Ticker Nerd's factor model ranks The Cigna Group 69 out of 100 as at 19 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the CI stock forecast for 2030?

No analyst covering The Cigna Group publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $290 to $400 over the next 12 months.

How has CI stock performed over the past year?

The Cigna Group returned -4.2% over the 12 months to 18 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does The Cigna Group do?

The Cigna Group is a global health company focused on providing health services, insurance products, and related support solutions. The company operates through two core business segments: Cigna Healthcare and Evernorth Health Services, which together serve employers, individuals, health plans, government programs, and other organizations.

What is the latest news on CI?

The most recent item we track (Zacks Investment Research, 18 Sept 2026): "Can Cigna's AI Push Help Rein In Rising Healthcare Costs?". Cigna (CI) is expanding its use of AI across care coordination and specialty pharmacy as part of efforts to manage elevated healthcare costs and improve access. The news highlights the company's ongoing push to apply artificial intelligence to health-plan operations.

Company

About The Cigna Group.

The Cigna Group is a global health company focused on providing health services, insurance products, and related support solutions. The company operates through two core business segments: Cigna Healthcare and Evernorth Health Services, which together serve employers, individuals, health plans, government programs, and other organizations. Its offerings include medical, dental, behavioral, disability, and life insurance, along with pharmacy benefit management, specialty pharmacy, care coordination, and other clinical and administrative services. The Cigna Group plays an important role in the healthcare market by connecting insurance coverage with pharmacy and care management capabilities, helping clients and members access coordinated health benefits and services across the United States and selected international markets. Headquartered in Bloomfield, Connecticut, The Cigna Group remains a major diversified healthcare services provider.

CEO Mr. Brian Case Evanko C.F.A. · 65,669 employees · United States · https://www.thecignagroup.com